SEC Form 4 · accession 0001209191-15-050300
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Gregory S Weishar
Officer — Chief Executive Officer · Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 4, 2015 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1 | Jun 2, 2015 | S | 15,661 | $33.2931 | D | 764,514 | D | |
| Common Stock, $0.01 par value | Jun 3, 2015 | S | 2,145 | $32.75 | D | 762,369 | D | |
| Common Stock, $0.01 par valueF2 | Jun 3, 2015 | S | 79,344 | $32.5016 | D | 683,025 | D | |
| Common Stock, $0.01 par valueF3 | Jun 3, 2015 | S | 7,000 | $32.6209 | D | 0 | I | By Spouse |
| Common Stock, $0.01 par value | holding | — | — | — | 1,500 | I | By Son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $33.25 and $33.50, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
- F2Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $32.50 and $32.68, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
- F3Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $32.62 and $32.63, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.